Skip to main content
Top
Published in: BMC Neurology 1/2016

Open Access 01-12-2016 | Case report

Friedreich Ataxia and nephrotic syndrome: a series of two patients

Authors: Julianna E. Shinnick, Charles J. Isaacs, Sharon Vivaldi, Kimberly Schadt, David R. Lynch

Published in: BMC Neurology | Issue 1/2016

Login to get access

Abstract

Background

Friedreich Ataxia (FRDA) is a neurodegenerative disorder characterized by gait and balance abnormalities, sensory loss, weakness, loss of reflexes, and ataxia. Previously, two cases of FRDA and Nephrotic Syndrome (NS) have been reported. Here we report two additional individuals with NS and FRDA, providing further evidence for a possible connection between the two diseases and focusing on the neuromuscular responsiveness of one individual to corticosteroid treatment, an effect not previously described in FRDA.

Case presentations

We describe two patients with FRDA also presenting with NS. The first patient was diagnosed with FRDA at age 5 and NS at age 7 following the development of periorbital edema, abdominal swelling, problems with urination, and weight gain. The second patient was diagnosed with NS at age 2 after presenting with periorbital edema, lethargy, and abdominal swelling. He was diagnosed with FRDA at age 10. Nephrotic syndrome was confirmed by laboratory testing in both cases and both individuals were treated with corticosteroids.

Conclusions

Nephrotic syndrome may occur in individuals with FRDA, but was not associated with myoclonic epilepsy in our patients as previously described. It is unlikely that this association is coincidental given the rarity of both conditions and the association of NS with mitochondrial disease in model systems, though coincidental coexistence is possible. One patient showed neurological improvement following steroid treatment. Although neurological improvement could be attributed to the treatment of NS, we also identified some degree of steroid responsiveness in a series of patients with FRDA but without NS.
Literature
2.
go back to reference Corben LA, Ho M, Copland J, Tai G, Delatycki MB. Increased prevalence of sleep-disordered breathing in Friedreich ataxia. Neurology. 2013;81(1):46–51.PubMedCrossRef Corben LA, Ho M, Copland J, Tai G, Delatycki MB. Increased prevalence of sleep-disordered breathing in Friedreich ataxia. Neurology. 2013;81(1):46–51.PubMedCrossRef
3.
go back to reference Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, et al. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013;260(9):2362–9.PubMedCrossRef Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, et al. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013;260(9):2362–9.PubMedCrossRef
4.
go back to reference Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87(2):168–74.PubMedCrossRef Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87(2):168–74.PubMedCrossRef
5.
go back to reference Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342(1–2):29–35.PubMedCrossRef Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342(1–2):29–35.PubMedCrossRef
6.
go back to reference Rance G, Corben L, Barker E, Carew P, Chisari D, Rogers M, et al. Auditory perception in individuals with Friedreich’s ataxia. Audiol Neurooto. 2010;15(4):229–40.CrossRef Rance G, Corben L, Barker E, Carew P, Chisari D, Rogers M, et al. Auditory perception in individuals with Friedreich’s ataxia. Audiol Neurooto. 2010;15(4):229–40.CrossRef
7.
go back to reference Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG. Management and therapy for cardiomyopathy in Fridreich’s ataxia. Expert Rev Cardiovasc Ther. 2012;10(6):767–77.PubMedCrossRef Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG. Management and therapy for cardiomyopathy in Fridreich’s ataxia. Expert Rev Cardiovasc Ther. 2012;10(6):767–77.PubMedCrossRef
8.
go back to reference Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Features of Friedreich’s ataxia: clinical and atypical phenotypes. J Neurochem. 2013;126(S1):103–17.PubMedCrossRef Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Features of Friedreich’s ataxia: clinical and atypical phenotypes. J Neurochem. 2013;126(S1):103–17.PubMedCrossRef
9.
go back to reference Puccio H, Kœnig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 2000;9(6):887–92.PubMedCrossRef Puccio H, Kœnig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 2000;9(6):887–92.PubMedCrossRef
10.
go back to reference García-Giménez J, Gimeno A, Gonzalez-Cabo P, Dasí F, Bolinches-Amorós A, Mollá B. Differential expression of PGC-1alpha and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One. 2011;6(6):e20666.PubMedPubMedCentralCrossRef García-Giménez J, Gimeno A, Gonzalez-Cabo P, Dasí F, Bolinches-Amorós A, Mollá B. Differential expression of PGC-1alpha and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One. 2011;6(6):e20666.PubMedPubMedCentralCrossRef
11.
go back to reference Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD, et al. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich’s ataxia. Cerebellum. 2006;5(4):257–67.PubMedCrossRef Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD, et al. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich’s ataxia. Cerebellum. 2006;5(4):257–67.PubMedCrossRef
12.
go back to reference Koeppen AH, Ramirez RL, Becker AB, Bjork ST, Levi S, Santambrogio P, et al. The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS. 2006;10(3):e0116396.CrossRef Koeppen AH, Ramirez RL, Becker AB, Bjork ST, Levi S, Santambrogio P, et al. The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS. 2006;10(3):e0116396.CrossRef
13.
go back to reference Strawser CJ, Schadt KA, Lynch DR. Therapeutic approaches for the treatment of Friedreich’s ataxia. Expert Rev Neurother. 2014;14(8):947–55.CrossRef Strawser CJ, Schadt KA, Lynch DR. Therapeutic approaches for the treatment of Friedreich’s ataxia. Expert Rev Neurother. 2014;14(8):947–55.CrossRef
14.
go back to reference Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, et al. Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand. 2015;132(1):7–15.PubMedCrossRef Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, et al. Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand. 2015;132(1):7–15.PubMedCrossRef
15.
go back to reference Watters GV, Zlotkin SH, Kaplan BS, Humphreys P, Drummond KN. Friedreich’s ataxia with nephrotic syndrome and convulsive disorder: clinical and neurophysiological studies with renal and nerve biopsies and an autopsy. Can J Neurol Sci. 1981;8(1):55–60.PubMed Watters GV, Zlotkin SH, Kaplan BS, Humphreys P, Drummond KN. Friedreich’s ataxia with nephrotic syndrome and convulsive disorder: clinical and neurophysiological studies with renal and nerve biopsies and an autopsy. Can J Neurol Sci. 1981;8(1):55–60.PubMed
17.
go back to reference Martín-Hernández E, García-Silva MT, Vara J, Campos Y, Cabello A, Muley R, et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol. 2005;20(9):183–8.CrossRef Martín-Hernández E, García-Silva MT, Vara J, Campos Y, Cabello A, Muley R, et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol. 2005;20(9):183–8.CrossRef
18.
go back to reference Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, et al. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012;27(9):1152–8.PubMedPubMedCentralCrossRef Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, et al. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012;27(9):1152–8.PubMedPubMedCentralCrossRef
20.
go back to reference Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123(12):5179.PubMedPubMedCentralCrossRef Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123(12):5179.PubMedPubMedCentralCrossRef
21.
go back to reference González‐Cabo P, Palau F. Mitochondrial pathophysiology in Friedreich’s ataxia. J Neurochem. 2013;126(s1):53–64.PubMedCrossRef González‐Cabo P, Palau F. Mitochondrial pathophysiology in Friedreich’s ataxia. J Neurochem. 2013;126(s1):53–64.PubMedCrossRef
22.
go back to reference Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997;276(5319):1709–12.PubMedCrossRef Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997;276(5319):1709–12.PubMedCrossRef
23.
go back to reference Puccio H, Simon S, Cossée M, Criqui-Filipe P, Tiziano F, Melki J. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27(2):181–6.PubMedCrossRef Puccio H, Simon S, Cossée M, Criqui-Filipe P, Tiziano F, Melki J. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27(2):181–6.PubMedCrossRef
24.
go back to reference Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215–7.PubMedCrossRef Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215–7.PubMedCrossRef
25.
go back to reference Pane M, Fanelli L, Mazzone ES, Olivieri G, D’Amico A, Messina S, et al. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test. Neuromuscul Disord. 2015. doi:10.1016/j.nmd.2015.07.009.PubMedCentral Pane M, Fanelli L, Mazzone ES, Olivieri G, D’Amico A, Messina S, et al. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test. Neuromuscul Disord. 2015. doi:10.​1016/​j.​nmd.​2015.​07.​009.PubMedCentral
26.
go back to reference Reeves EK, Rayavarapu S, Damsker JM, Nagaraju K. Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases. Endocr Metab Immune Disord Drug Targets. 2012;12(1):95–103.PubMedCrossRef Reeves EK, Rayavarapu S, Damsker JM, Nagaraju K. Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases. Endocr Metab Immune Disord Drug Targets. 2012;12(1):95–103.PubMedCrossRef
27.
go back to reference Broccoletti T, Del Giudice E, Cirillo E, Vigliano I, Giardino G, Ginocchio VM, et al. Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol. 2011;18(4):564–70.PubMedCrossRef Broccoletti T, Del Giudice E, Cirillo E, Vigliano I, Giardino G, Ginocchio VM, et al. Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia. Eur J Neurol. 2011;18(4):564–70.PubMedCrossRef
28.
go back to reference Obis E, Irazusta V, Sanchis D, Ros J, Tamarit J. Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism. Free Radic Biol Med. 2014;73:21–33.PubMedCrossRef Obis E, Irazusta V, Sanchis D, Ros J, Tamarit J. Frataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism. Free Radic Biol Med. 2014;73:21–33.PubMedCrossRef
29.
go back to reference Navarro JA, Ohmann E, Sanchez D, Botella JA, Liebisch G, Moltó MD, et al. Altered lipid metabolism in a Drosophila model of Friedreich’s ataxia. Hum Mol Genet. 2010;19(14):2828–40.PubMedCrossRef Navarro JA, Ohmann E, Sanchez D, Botella JA, Liebisch G, Moltó MD, et al. Altered lipid metabolism in a Drosophila model of Friedreich’s ataxia. Hum Mol Genet. 2010;19(14):2828–40.PubMedCrossRef
Metadata
Title
Friedreich Ataxia and nephrotic syndrome: a series of two patients
Authors
Julianna E. Shinnick
Charles J. Isaacs
Sharon Vivaldi
Kimberly Schadt
David R. Lynch
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0526-2

Other articles of this Issue 1/2016

BMC Neurology 1/2016 Go to the issue